Chen XY - Search Results

1

Pharmacodynamic, pharmacokinetic, and phase 1a study of bisthianostat, a novel histone deacetylase inhibitor, for the treatment of relapsed or refractory multiple myeloma.

Zhou YB, Zhang YM, Huang HH, Shen LJ, Han XF, Hu XB, Yu SD, Gao AH, Sheng L, Su MB, Wei XL, Zhang Y, Zhang YF, Gao ZW, Chen XY, Nan FJ, Li J, Hou J. Zhou YB, et al. Among authors: chen xy. Acta Pharmacol Sin. 2022 Apr;43(4):1091-1099. doi: 10.1038/s41401-021-00728-y. Epub 2021 Aug 2. Acta Pharmacol Sin. 2022. PMID: 34341512 Free PMC article. Clinical Trial.

2

Pharmacokinetics of loratadine and its active metabolite descarboethoxyloratadine in healthy Chinese subjects.

Zhang YF, Chen XY, Zhong DF, Dong YM. Zhang YF, et al. Among authors: chen xy. Acta Pharmacol Sin. 2003 Jul;24(7):715-8. Acta Pharmacol Sin. 2003. PMID: 12852841 Free article. Clinical Trial.

3

[Determination of lornoxicam in human plasma by LC/MS/MS].

Zeng YL, Chen XY, Zhang YF, Zhong DF. Zeng YL, et al. Among authors: chen xy. Yao Xue Xue Bao. 2004 Feb;39(2):132-5. Yao Xue Xue Bao. 2004. PMID: 15127622 Chinese.

4

[Determination of dextrorphan in human plasma and pharmacokinetic study].

Liu D, Chen XY, Zhang YF, Zhong DF, Gu Q, Zhang Y. Liu D, et al. Among authors: chen xy. Yao Xue Xue Bao. 2004 Jun;39(6):449-52. Yao Xue Xue Bao. 2004. PMID: 15491104 Chinese.

5

Simultaneous determination of methylephedrine and noscapine in human plasma by liquid chromatography-tandem mass spectrometry.

Zhu L, Chen X, Zhang Y, Yu H, Zhong D. Zhu L, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jun 25;820(2):175-82. doi: 10.1016/j.jchromb.2005.03.010. Epub 2005 Apr 22. J Chromatogr B Analyt Technol Biomed Life Sci. 2005. PMID: 15899371

6

Influence of dosage forms on pharmacokinetics of daidzein and its main metabolite daidzein-7-O-glucuronide in rats.

Qiu F, Chen XY, Song B, Zhong DF, Liu CX. Qiu F, et al. Among authors: chen xy. Acta Pharmacol Sin. 2005 Sep;26(9):1145-52. doi: 10.1111/j.1745-7254.2005.00187.x. Acta Pharmacol Sin. 2005. PMID: 16115384

7

[Impact of cytochrome P450 CYP2C9 variant allele CYP2C9 * 3 on the pharmacokinetics of glibenclamide and lornoxicam in Chinese subjects].

Zhang YF, Chen XY, Guo YJ, Si DY, Zhou H, Zhong DF. Zhang YF, et al. Among authors: chen xy. Yao Xue Xue Bao. 2005 Sep;40(9):796-9. Yao Xue Xue Bao. 2005. PMID: 16342679 Chinese.

8

[Determination of risperidone in human plasma by liquid chromatography-tandem mass spectrometry].

Duan XT, Chen XY, Zhang YF, Zhong DF. Duan XT, et al. Among authors: chen xy. Yao Xue Xue Bao. 2006 Jul;41(7):684-8. Yao Xue Xue Bao. 2006. PMID: 17007366 Clinical Trial. Chinese.

9

Pharmacokinetics of telmisartan in healthy Chinese subjects after oral administration of two dosage levels.

Zhang P, Zhang Y, Chen X, Li R, Yin J, Zhong D. Zhang P, et al. Arzneimittelforschung. 2006;56(8):569-73. doi: 10.1055/s-0031-1296753. Arzneimittelforschung. 2006. PMID: 17009837 Clinical Trial.

10

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects.

Zhang Y, Si D, Chen X, Lin N, Guo Y, Zhou H, Zhong D. Zhang Y, et al. Br J Clin Pharmacol. 2007 Jul;64(1):67-74. doi: 10.1111/j.1365-2125.2007.02846.x. Epub 2007 Feb 12. Br J Clin Pharmacol. 2007. PMID: 17298483 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,978 results

Search Page

Filters